Gil Bar-Sela

Summary

Country: Israel

Publications

  1. ncbi request reprint Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study
    Gil Bar-Sela
    Division of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa 31096, Israel
    Nutr Cancer 58:43-8. 2007
  2. doi request reprint Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus, and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Eur J Cancer 49:1058-64. 2013
  3. doi request reprint Collision tumor of the mediastinum: a rare entity
    Orit Kaidar-Person
    Division of Oncology, Rambam Health Care Campus and Technion Israel Institute of Technology, Haifa, Israel
    Ann Thorac Surg 95:330-2. 2013
  4. doi request reprint Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer
    Haitam Nasrallah
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, POB 9602, Haifa 31096, Israel
    Med Oncol 29:212-4. 2012
  5. doi request reprint Treatment of adult patients with Ewing's sarcoma: compliance with chemotherapy protocols & toxicity
    Orit Kaidar-Person
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, POB 9602, 31096 Haifa, Israel
    Med Oncol 28:S685-9. 2011
  6. doi request reprint Disseminated carcinoma diagnosed by bone marrow biopsy in patients with microangiopathic hemolytic anemia and thrombocytopenia: a report of two cases with gastric cancer and a review of the literature
    Orit Kaidar-Person
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, POB 9602, Haifa 31096, Israel
    J Gastrointest Cancer 42:123-6. 2011
  7. ncbi request reprint Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: association with severe myelotoxicity
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Med Oncol 20:291-4. 2003
  8. doi request reprint Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Jpn J Clin Oncol 40:163-5. 2010
  9. ncbi request reprint [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?]
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Harefuah 145:42-6, 77. 2006
  10. doi request reprint A preliminary report on innovative group therapy in an oncology in-patient department: a patient-family-staff community meeting
    Liron Eliasov
    Division of Oncology, Rambam Health Care Campus, and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Psychooncology 20:1126-9. 2011

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study
    Gil Bar-Sela
    Division of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa 31096, Israel
    Nutr Cancer 58:43-8. 2007
    ..These preliminary results need confirmation in a phase III study...
  2. doi request reprint Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus, and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Eur J Cancer 49:1058-64. 2013
    ....
  3. doi request reprint Collision tumor of the mediastinum: a rare entity
    Orit Kaidar-Person
    Division of Oncology, Rambam Health Care Campus and Technion Israel Institute of Technology, Haifa, Israel
    Ann Thorac Surg 95:330-2. 2013
    ..The present case is of 2 histologically distinct tumors with aggressive features occurring at the mediastinum...
  4. doi request reprint Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer
    Haitam Nasrallah
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, POB 9602, Haifa 31096, Israel
    Med Oncol 29:212-4. 2012
    ..Physicians should be aware of the potential severe lung toxicity of this combination. The potential role of corticosteroids in the management of this toxicity is unknown...
  5. doi request reprint Treatment of adult patients with Ewing's sarcoma: compliance with chemotherapy protocols & toxicity
    Orit Kaidar-Person
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, POB 9602, 31096 Haifa, Israel
    Med Oncol 28:S685-9. 2011
    ..Treatment protocols used in the pediatric population, including high-dose chemotherapy, should be adapted for the adult population...
  6. doi request reprint Disseminated carcinoma diagnosed by bone marrow biopsy in patients with microangiopathic hemolytic anemia and thrombocytopenia: a report of two cases with gastric cancer and a review of the literature
    Orit Kaidar-Person
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, POB 9602, Haifa 31096, Israel
    J Gastrointest Cancer 42:123-6. 2011
    ..Malignancy is often associated with hematological disorders, but rarely is the diagnosis of malignancy secondary to the diagnosis of microangiopathic hemolytic anemia and thrombocytopenia...
  7. ncbi request reprint Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: association with severe myelotoxicity
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Med Oncol 20:291-4. 2003
    ..Nonhematological toxicity was moderate. We conclude that the current regimen of paclitaxel, carboplatin, and oral etoposide is not recommended in advanced gastric carcinoma owing to unacceptable myelotoxicity...
  8. doi request reprint Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumor
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Jpn J Clin Oncol 40:163-5. 2010
    ..Oral desensitization appears to be an option for patients with hypersensitivity type I to sunitinib and may permit its safe administration to patients who experience HSR to this life-prolonging medication...
  9. ncbi request reprint [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?]
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Harefuah 145:42-6, 77. 2006
    ..In the future, data that will be obtained from good quality studies might facilitate reaching firm conclusions regarding the therapeutic benefit of mistletoe preparation for oncological treatment...
  10. doi request reprint A preliminary report on innovative group therapy in an oncology in-patient department: a patient-family-staff community meeting
    Liron Eliasov
    Division of Oncology, Rambam Health Care Campus, and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Psychooncology 20:1126-9. 2011
    ..It is designed to answer the needs of in-patients and family members for open communication and empathic interaction and to serve as a model for effective coping...
  11. doi request reprint Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experience
    Mark Shilkrut
    Division of Oncology, Rambam Health Care Campus, Haifa, Israel
    Am J Clin Oncol 33:79-82. 2010
    ..One patient (10%) had thrombocytopenia and 2 patients (20%) developed subclinical hypothyroidism. Hormonal and symptomatic relief can be achieved with 131-MIBG therapy in patients with MPCC and MPGG with minor side effects...
  12. ncbi request reprint Initiating palliative care conversations: lessons from Jewish bioethics
    Michael Schultz
    Division of Oncology, Rambam Health Care Campus, Haifa, Israel
    J Support Oncol 11:1-7. 2013
    ..Staff members can play a vital role in helping patients make the most of this new period of their lives...
  13. doi request reprint "Balint group" meetings for oncology residents as a tool to improve therapeutic communication skills and reduce burnout level
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus, and Faculty of Medicine, Technion Israel Institute of Technology, POB 9602, Haifa, 31096, Israel
    J Cancer Educ 27:786-9. 2012
    ..It was felt that participation in a Balint group could improve communication abilities of residents and contribute to their feelings of self-accomplishment as doctors...
  14. doi request reprint The two major epidemics of the twenty-first century: obesity and cancer
    Orit Kaidar-Person
    Division of Oncology, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Obes Surg 21:1792-7. 2011
    ..This review will point out the potential mechanism linking obesity and cancer and will discuss several challenges in various treatment modalities of cancer in obese patients...
  15. ncbi request reprint Abnoba-viscum (mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, POB 9602, Haifa 31096, Israel
    Med Oncol 21:251-4. 2004
    ..Toxicity was mild and included mainly local inflammatory reaction. In conclusion, mistletoe extract does not seem to be active in metastatic colorectal cancer resistant to 5FU/LCV in terms of objective tumor response...
  16. doi request reprint Treatment of lower extremity edema by subcutaneous drainage in palliative care of advanced cancer patients
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus, and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Am J Hosp Palliat Care 27:272-5. 2010
    ..Lower extremity edema is a problem in patients with advanced cancer, causing decreased physical function and reduced movement...
  17. ncbi request reprint Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality
    Eran Ben-Arye
    The Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Support Care Cancer 14:147-52. 2006
    ..Complementary and alternative medicine (CAM) is increasingly being used by patients with cancer...
  18. ncbi request reprint Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Anticancer Res 26:709-13. 2006
    ..Malignant ascites is a major problem in the management of advanced stages of certain malignancies. The possibility of reducing the accumulation of ascites by intraperitoneal injections of a Viscum album extract (Iscador M) was evaluated...
  19. ncbi request reprint [Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients]
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Harefuah 145:2-7, 80. 2006
    ..We conclude that imatinib is a safe and highly effective therapy for GIST patients with unresectable or metastatic disease, providing new hope for durable remission in these patients...
  20. ncbi request reprint Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults
    Gil Bar-Sela
    Department of Oncology, Rambam Medical Center and Technion Israel Institute of Technology, Haifa 31096, Israel
    Pediatr Blood Cancer 45:291-7. 2005
    ....